FDA Panel Recommends Label Change for Low T Usage
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. There could be major changes ahead in the prescribing recommendations for drugs that treat low testosterone. A blue-ribbon expert panel voted overwhelmingly on Wednesday for the Food and Drug Administration to impose strict new limitations on the multibillion-dollar testosterone drug industry,
Read MorePower Morcellation Devices Linked to Cancer
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. FDA discourages use of laparoscopic power morcellation for removal of uterus or uterine fibroids. In a safety communication notice, the U.S. Food and Drug Administration discouraged the use of laparoscopic power morcellation for the removal of the uterus (hysterectomy) or uterine fibroids
Read MoreConsumer Alert! Viagra Link to Skin Cancer
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. A new study shows a possible link between popular erectile dysfunction drugs and an increased risk of developing a deadly form of skin cancer. The disturbing link comes from a large study in JAMA Internal Medicine that followed nearly 26,000 men who had
Read MoreTestosterone Supplements Linked to Life Threatening Cardiac Events
The latest data is out on the correlation between treatments for so-called “Low T” and cardiac events such as heart, attack, stroke and pulmonary embolism, and the results are truly frightening. The most recent study was funded by the National Institutes of Health and published in the journal of PLOS ONE. The study evaluated over 55,000
Read MoreFDA Recommends Discontinuing Tylenol Combination Drug Products
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. The woes for Tylenol just keep getting worse. Today, the FDA is recommending health care professionals discontinue prescribing and dispensing prescription combination drug products that contain more than 325 milligrams (mg) of acetaminophen per tablet, capsule or other dosage unit. There
Read MoreTRUEtrack and TRUEbalance Blood Glucose Meters Recalled
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Attention all diabetes! Nipro Diagnostics initiated a voluntary recall and replacement of a limited number of TRUEbalance and TRUEtrack Blood Glucose Meters distributed both in the United States and outside the United States. The company determined that certain isolated TRUEbalance and
Read MoreMerry Christmas from The Michael Brady Lynch Firm
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. On this Christmas Eve, I am thankful for the many blessing of my life. It is also a time of reflection to remember the true meaning of Christmas. I think Linus said it best in “A Charlie Brown Christmas” when he
Read MorePopular Antipsychotics Triple Risk of Diabetes in Children
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Antipsychotic medications such as Seroquel, Abilify, and Risperdal can triple a child’s risk of developing type 2 diabetes within the first year of usage, according to a new study. Doctors use powerful antipsychotics to treat schizophrenia. Now the majority of prescriptions
Read MoreThe Michael Brady Lynch Firm Announces Newest Attorney Yvonne Hua
This is Michel Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. On behalf of the attorneys and staff of The Michael Brady Lynch Firm, we are proud to announce the latest addition to the team, Attorney Yvonne Hua! Attorney Yvonne Hua is first generation Chinese-American and is fluent in both English and
Read MoreLevaquin and Cipro Add Increased Warnings
This Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. The safety profile of the class of drugs which include Levaquin, Cipro, Avelox, Noroxin, Floxin and Factive just keeps getting worse. Today the FDA has required the drug labels and Medication Guides for all fluoroquinolone antibacterial drugs be updated to better describe
Read More